Status:
UNKNOWN
The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction
Lead Sponsor:
University of British Columbia
Conditions:
Pain, Postoperative
Eligibility:
All Genders
12-17 years
Phase:
PHASE1
Brief Summary
This study evaluates the effect of a femoral nerve block on opioid requirements following anterior cruciate ligament (ACL) reconstruction. This is a double blind, prospective randomized controlled tri...
Eligibility Criteria
Inclusion
- Schedule for primary elective anterior cruciate ligament reconstruction
- Tolerance to bupivacaine
- Tolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
- Informed consent
Exclusion
- Patients who received a femoral nerve block more than 1 hour prior to surgery
- Complex associated injuries or pre-existing conditions that will delay time to ambulation
- Children with tibial avulsion fractures
- Allergic and/or sensitive to bupivacaine and/or NSAIDs
- 30% over ideal body weight
- Acute ACL reconstruction (done less than 2 weeks after injury)
- Pre-existing femoral nerve injury
- Psychiatric patients on psychotropic agents
- History of drug or alcohol dependence or recreational drug use
- Refusal to provide informed consent
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00175630
Start Date
December 1 2010
End Date
September 1 2016
Last Update
June 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Children's Hospital, Department of Orthopaedics
Vancouver, British Columbia, Canada, V6H 3V4